Stocks and InvestingStocks and Investing
Mon, April 11, 2022
Sun, April 10, 2022
Fri, April 8, 2022
Thu, April 7, 2022

Uy Ear Maintained (ARQT) at Strong Buy with Decreased Target to $57 on, Apr 7th, 2022


Published on 2024-10-27 20:21:42 - WOPRAI, Uy Ear
  Print publication without navigation


Uy Ear of Mizuho, Maintained "Arcutis Biotherapeutics, Inc." (ARQT) at Strong Buy with Decreased Target from $58 to $57 on, Apr 7th, 2022.

Uy has made no other calls on ARQT in the last 4 months.



There is 1 other peer that has a rating on ARQT. Out of the 1 peers that are also analyzing ARQT, 0 agree with Uy's Rating of Hold.



This is the rating of the analyst that currently disagrees with Uy


  • David Lebowitz of "Morgan Stanley" Maintained at Buy with Increased Target to $37 on, Wednesday, March 2nd, 2022